Kathleen Forrester

Merck & Co., Inc., Rahway, NJ, USA (United States)United States

Medicine · Health Sciences

18h-index6.8kcitations27works0.32yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?


Research Topics

Cancer-related Molecular Pathways(13), Cancer Research and Treatments(5), Epigenetics and DNA Methylation(4), Pancreatic and Hepatic Oncology Research(3), Neuroendocrine Tumor Research Advances(3)

Publications27 total

2024· 1 cited
Journal of Public Health Dentistry·1997· 38 citedOpen Access
Genes & Development·1996· 315 citedOpen Access
Proceedings of the National Academy of Sciences·1996· 465 citedOpen Access
Effects of p53 mutants on wild-type p53-mediated transactivation are cell type dependent.
PubMed·1995· 101 cited
Nature Genetics·1995· 554 citedOpen Access
Proceedings of the National Academy of Sciences·1994· 543 citedOpen Access
Cold Spring Harbor Symposia on Quantitative Biology·1994· 32 cited
Allelic frequency of a p53 polymorphism in human lung cancer.
PubMed·1993· 86 cited
page 1 of 2Next →

Frequent Co-authors

Concepción Almoguera(7), Manuel Perucho(7), C C Harris(7), Xin Wei Wang(6), Curtis C. Harris(6), Elisa A. Spillare(5), S. Perwez Hussain(4), Shawn E. Lupold(4), Jill D. Coursen(4), Heidi Yeh(3), Aikou Okamoto(3), B I Gerwin(3), Edward Winter(3), Juan Jordano(3), William P. Bennett(3), Norman Arnheim(2), Jan H.J. Hoeijmakers(2), Douglas J. Demetrick(2), Manuel Serrano(2), David Beach(2)